Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis

PLoS Medicine(2024)10.1371/journal.pmed.1004411Source: DataRank Database

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis is a research paper published in PLoS Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.38)OA: goldTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Robert J. Commons ORCID,Nguyễn Hoàng Châu ORCID,Cindy S. Chu ORCID,Nicholas Day ORCID,Gavin Koh ORCID

Live enrichment

PubMed:39331646 OpenAlex:https://openalex.org/W4402917595

National Health and Medical Research Council

Grant: 2008501

National Health and Medical Research Council

Grant: 1194701

Wellcome Trust

Grant: 220211

Wellcome Trust

Grant: 089179

Wellcome Trust

Grant: 223253/Z/21/Z

Wellcome Trust

Grant: 093956/Z/10/C

Wellcome Trust

FWCI

1.38

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004411&type=printable

publisherhttps://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004411&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pmed.1004411

journalhttps://doi.org/10.1371/journal.pmed.1004411

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39331646

Fields of Study

Malaria Research and ControlVector-borne infectious diseasesHematological disorders and diagnosticsMalaria, VivaxHumansPrimaquineAntimalarialsMethemoglobinBiomarkersPlasmodium vivaxRecurrenceTreatment Outcome

MeSH Terms

AntimalarialsHumansMethemoglobinPlasmodium vivaxPrimaquineRecurrenceBiomarkersMalaria, VivaxTreatment Outcome

Keywords

PrimaquineMedicinePlasmodium vivaxCochrane LibraryMalariaMethemoglobinInternal medicineMeta-analysisSurrogate endpointClinical trialImmunologyPlasmodium falciparumChloroquineHemoglobin

Sustainable Development Goals

SDG 0: Good health and well-being